Yüklüyor......
Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges
The mammalian (or mechanistic) target of rapamycin (mTOR) pathway has a key role in the regulation of a variety of biological processes pivotal for cellular life, aging, and death. Impaired activity of mTOR complexes (mTORC1/mTORC2), particularly mTORC1 overactivation, has been implicated in a pleth...
Kaydedildi:
| Yayımlandı: | Oxid Med Cell Longev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231362/ https://ncbi.nlm.nih.gov/pubmed/30510618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/3693625 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|